Trials show that digitoxin—active ingredient in foxglove—lowered mortality & hospitalisation in patients with reduced heart-pumping function, insufficient emptying of left ventricle.
Inclisiran was developed by Novartis & launched in India in January this year under brand name Leqvio. Cardiologist vouch for benefits, say it has been a useful addition to therapies.
Report by Asia-Pacific Society of Cardiology says heart failure burden ranges from 1.3 to 6.7% in South Asian countries. Calls for ‘cancer-level’ urgency to tackle condition.
Doctors are recommending cardiac screening for competitive athletes who have recovered from Covid-19, including for those who didn't show any obvious symptoms.
India’s private sector remains hesitant to invest in R&D. This is understandable, as the domestic market often fails to reward differentiated technologies adequately.
Speaking at ThePrint OTC Thursday, NSE CEO Ashishkumar Chauhan said the exchange has been trying to list itself since 2016, but it couldn’t happen due to one reason or the other.
Mechanical engineer & alumnus of IIM-A & IAS France, Kota was General Manager in HAL’s Light Combat Aircraft division. He was selected from a pool of eight candidates.
No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.
COMMENTS